WYPR
May 19, 2026
Scott Maucione
Excerpt:
The limit will go into effect next year. Also in 2028, the drug will be eligible for limits on all insurance plans in Maryland, potentially saving customers millions of dollars in total.
“Because of Ozempic’s popularity, the, and because the manufacturers have patent exclusivity, the price has been set very high, so it’s both been a strain on our health care system as health plans struggle to keep up with the demand and cover that,” said Cathrine Kirk Robins, the deputy director of Maryland Healthcare for All! a medical affordability nonprofit. “It’s also been hard for patients to afford it when they want to because it’s off label as well.”
Read the full article at WYPR.org.
Last modified: May 21, 2026
